Single-cell transcriptomics predict novel potential regulators of acute epithelial restitution in the

Insights

Neonatal pigs with intestinal injury show impaired barrier repair. Colony stimulating factor-1 (CSF-1) shows potential as a therapeutic target to improve intestinal restitution in neonates.

Area of Science:

  • Gastroenterology
  • Developmental Biology
  • Regenerative Medicine

Background:

  • Intestinal ischemic injury compromises the epithelial barrier, increasing sepsis risk.
  • Neonates exhibit heightened susceptibility to intestinal barrier dysfunction and injury compared to older individuals.
  • Existing pig models demonstrate age-dependent intestinal barrier repair failure, with rescue possible via juvenile tissue application, but underlying mechanisms are unclear.

Purpose of the Study:

  • To identify novel upstream regulators of age-dependent intestinal restitution programs.
  • To pinpoint specific enterocyte subpopulations involved in epithelial repair.
  • To explore potential therapeutic targets for neonatal intestinal injury.

Main Methods:

  • Single-cell RNA sequencing of jejunal epithelial cells from recovering ischemic juvenile pigs.
  • Prediction and validation of upstream regulators using porcine intestinal epithelial cells (IPEC-J2) and banked tissues.
  • Immunohistochemical analysis of CSF-1 and CSF1R expression in neonatal and juvenile pig tissues.
  • In vitro assessment of restitution using a scratch wound assay with a CSF1R inhibitor.

Main Results:

  • A subcluster of restituting enterocytes expressing cell migration pathways was identified.
  • Colony stimulating factor-1 (CSF-1) was predicted as a key upstream regulator.
  • CSF-1 and its receptor CSF1R were found in wound-adjacent and restituting epithelial cells in juvenile and rescued neonatal pigs.
  • Inhibition of CSF1R impaired epithelial restitution in vitro.

Conclusions:

  • The study validates an approach to identify upstream regulators of epithelial restitution.
  • CSF-1 emerges as a potential molecular mediator for improving intestinal repair in neonatal injury.
  • Findings support CSF-1 as a therapeutic target for ischemia-mediated intestinal injury in neonates.